4.4 Article

Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial

Journal

DRUG AND ALCOHOL DEPENDENCE
Volume 227, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2021.108917

Keywords

Medication adherence; Mobile health; mHealth; Opioid related disorders; Buprenorphine; Directly-observed therapy

Funding

  1. Small Business Innovation Research (SBIR) grant from NIH/NIDA [R44DA044053]
  2. University of Washington's Center for AIDS Research (CFAR) for HIV related research and prevention through the NIAID [P30AI027757]
  3. health technology company (emocha Mobile Health, Inc. emocha)

Ask authors/readers for more resources

The pilot study evaluating the feasibility of video directly observed therapy (DOT) for patients initiating buprenorphine did not show better outcomes for opioid use disorder (OUD) compared to treatment-as-usual (TAU). The low rates of intervention use may have contributed to these findings.
Background: We conducted a pilot study to assess feasibility of using video directly-observed therapy (DOT) for patients initiating buprenorphine to evaluate whether it is associated with better opioid use disorder (OUD) outcomes when compared to treatment-as-usual (TAU). Methods: Pilot randomized controlled trial of adult patients with OUD initiating buprenorphine treatment (n = 78) at two sites (Seattle, WA and Boston, MA) from January 2019 to May 2020. Intervention was video DOT using a HIPAA-compliant smartphone application to record taking daily buprenorphine. Study smartphones, text reminders to upload a video, and calendar summaries of video DOT adherence were provided. Main outcomes were 1) percentage of 12 weekly urine drug tests (UDT) negative for illicit opioids and 2) engagement in treatment at week 12 (i.e., having an active prescription for buprenorphine within the last 7 days). Results: Of 78 enrolled, 20 (26 %) were female; 29 (37 %) non-white; and 31 (40 %) homeless. The mean (standard deviation) percentage of doses confirmed by video was 31 % (34 %). In intention-to-treat analysis, the average percentage of weekly opioid negative UDT was 50 % (95 % CI: 40-63 %) in the intervention arm versus 64 % (95 % CI: 55-74 %) among controls; RR = 0.78 (95 % CI: 0.60-1.02, p = 0.07). Engagement at week 12 was 69 % (95 % CI: 56-86 %) v. 82 % (95 % CI: 71-95 %) in the intervention vs. TAU arms, respectively; RR = 0.84 (95 % CI: 0.65-1.10, p = 0.20). Conclusions: The video DOT intervention did not result in improvements in illicit opioid use and treatment engagement compared to TAU. The study was limited by low rates of intervention use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available